"Pushpawati Singhania Hospital & Research Institute (PSRI Hospital) is a multi specialty Hospital of national & international repute. PSRI was established in year 1996 as South East Asia's first and India's foremost institutes providing advanced and comprehensive medical and surgical treatment. it is one of the top multi specialty hospitals in Delhi NCR. PSRI Hospital is famous for its clinical talent pool, quality of care and high level patient satisfaction & ambiance. Ranked as the best multi specialty hospital in Delhi NCR, we aim to provide world class heath care services in more then 50 specialties."

During the past decade, Pushpawati Singhania Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pushpawati Singhania Research Institute" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Cristcot LLC" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Indian Society of Critical Care Medicine" with 1 trials sponsored and "Intercell USA, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pushpawati Singhania Research Institute" #1 collaborator was "Cristcot HCA LLC" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Indian Society of Critical Care Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pushpawati Singhania Research Institute" are "Colitis, Ulcerative" (1 trials), "Critical Illness" (1 trials), "ICD" (1 trials), "Septic Shock" (1 trials) and "Tachycardia" (1 trials). Many other conditions were trialed in "Pushpawati Singhania Research Institute" in a lesser frequency.

Most popular intervention types in "Pushpawati Singhania Research Institute" are "Other" (3 trials), "Drug" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Etrolizumab" (1 trials), "No Intervention" (1 trials), "Observation" (1 trials) and "Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pushpawati Singhania Research Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Pushpawati Singhania Research Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Pushpawati Singhania Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pushpawati Singhania Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".